Narrow search
Showing 1 - 10 of 125
Cover Image
The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997 - 2010 : evidence from longitudinal, disease-level data
Lichtenberg, Frank R.; Pettersson, Billie - In: Economics of innovation and new technology 23 (2014) 3/4, pp. 239-273
Persistent link: https://www.econbiz.de/10010407486
Cover Image
The impact of pharmaceutical innovation on longevity and medical expenditure in France : 2000 - 2009
Lichtenberg, Frank R. - In: Economics and human biology 13 (2014), pp. 107-127
Persistent link: https://www.econbiz.de/10010386634
Cover Image
Public Policy and Innovation in the U.S. Pharmaceutical Industry
Lichtenberg, Frank R. - 2013
Public policy can impact innovation, eitherencouraging or inhibiting the creation of innovative technologies ….Howfive public policies have impacted continued innovation within the U.S.pharmaceutical industry is examined.At issue are the 1962 …
Persistent link: https://www.econbiz.de/10014201854
Cover Image
Chapter 15 Economics of defense R&D
Lichtenberg, Frank R. - In: Handbook of defense economics : volume 1, (pp. 431-457). 1995
This chapter examines a number of aspects of defense R&D, including: mechanisms — design competitions, and independent R&D subsidies — used by the US government to encourage firms to invest their own funds in defense R&D; theory and evidence concerning both the private and social benefits of,...
Persistent link: https://www.econbiz.de/10014024416
Cover Image
The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003-2013
Lichtenberg, Frank R. - In: Latin American Economic Review 26 (2017) 1, pp. 1-22
I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003-2013, by ….) that were subject to more pharmaceutical innovation, controlling for changes in the age-standardized cancer incidence rate … of cancer drug innovation to Mexican longevity growth has been valuable, but, perhaps, it could have been even larger …
Persistent link: https://www.econbiz.de/10011994326
Cover Image
Spurious correlation in estimation of the health production function: A note
Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …
Persistent link: https://www.econbiz.de/10010315553
Cover Image
Spurious correlation in estimation of the health production function: A note
Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health …
Persistent link: https://www.econbiz.de/10010285825
Cover Image
Spurious correlation in estimation of the health production function : a note
Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health … ; Innovation ; Pharmaceuticals ; Health care expenditure ; Cointegration …
Persistent link: https://www.econbiz.de/10003900852
Cover Image
Spurious correlation in estimation of the health production function : a note
Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health … ; Innovation ; Pharmaceuticals ; Health care expenditure ; Cointegration …
Persistent link: https://www.econbiz.de/10003909500
Cover Image
The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010 : evidence from longitudinal, disease-level data
Lichtenberg, Frank R.; Pettersson, Billie - 2012
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …
Persistent link: https://www.econbiz.de/10009571756